Chemed Corp

Chemed Corp(CHE)股票分析

$512.900

-0.103 (-0.02%)收盘时

Loading chart…
最高
522.340
开盘
515.180
成交量加权均价
515.18
成交量
127.66K
市值
8.22B
最低
510.300
成交额
65.77M
企业价值/息税折旧摊销前利润(TTM)
15.58

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

AI 分析 of Chemed Corp (CHE)

买入

Chemed Corp is a good buy right now due to its current price of $512.98, which is below the median analyst price target of $549, suggesting a potential upside of 7.1%. Additionally, the forward P/E ratio of 18.18 indicates that the stock is reasonably valued compared to its expected earnings growth. The recent positive analyst coverage and the company's strong revenue growth, with Q2 2026 revenue reported at $673.25 million, support a bullish outlook. However, the main risk is the insider selling activity, with an executive selling 1,000 shares, which could signal caution among insiders.

分析师评级(4)

上行空间 +6.71%
持有
1 买入
3 持有
0 卖出
当前: 512.90
最低
475.00
平均
547.33
最高
595.00

UBS

2026-09-25

目标价

$650

买入

Oppenheimer

2026-07-31

目标价

$590

跑赢大盘

RBC Capital

2026-07-30

目标价

$548

Sector Perform

BofA

2026-07-09

目标价

$510

中性

RBC Capital

2026-04-27

目标价

$436

Sector Perform

估值指标

Chemed Corp(CHE)当前预期市盈率为 18.90,5 年平均预期市盈率为 22.77。

预期市盈率

低估
5 年均值 P/E
22.77
当前P/E
18.90
高估
25.61
低估
19.93

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.66
当前EV/EBITDA
15.58
高估
17.43
低估
13.90

预期市销率

低估
5 年均值 P/S
3.09
当前P/S
2.32
高估
3.63
低估
2.55

Alphio AI 对 CHE 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CHE

$709.68

情景价格

基

基准

基准 · 50%CHE

$700.04

情景价格

悲

悲观

悲观 · 25%CHE

$601.39

情景价格

持有 CHE 的大户

A

Aptus Capital Advisors, LLC

+ 持有CHE

+6.52%

3个月收益率

R

River Road Asset Management, LLC

+ 持有CHE

-6.99%

3个月收益率

事件时间线

2026-08-06 (ET)

12:00:00

Chemed Corporation Declares Quarterly Cash Dividend of $0.70 per Share

2026-07-28 (ET)

16:30:00

Company Revises Guidance, Expected EPS at $24.34

16:30:00

Company Reports Q2 Revenue of $673.25M, Beating Consensus

2026-04-23 (ET)

16:30:00

Chemed Reports Q1 Revenue of $657.5M

资讯

CHE 常见问题 —— 由 Alphio AI 解答

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Chemed Corp is a good buy right now due to its current price of $512.98, which is below the median analyst price target of $549, suggesting a potential upside of 7.1%. Additionally, the forward P/E ratio of 18.18 indicates that the stock is reasonably valued compared to its expected earnings growth. The recent positive analyst coverage and the company's strong revenue growth, with Q2 2026 revenue reported at $673.25 million, support a bullish outlook. However, the main risk is the insider selling activity, with an executive selling 1,000 shares, which could signal caution among insiders.

4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易